Navigation Links
Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
Date:5/22/2013

CT lung densitometry to measure the degree of lung tissue preservation over time. The SPARTA study will be a multicenter trial and is scheduled to begin in the second half of 2013.

About Grifols

Grifols is a global healthcare company with a 70-year legacy of improving people's health and well-being through the development of life-saving plasma medicines, hospital pharmacy products, and diagnostic technology for clinical use.

As a leading producer of plasma medicines, Grifols has a presence in more than 100 countries and is the world leader in plasma collection, with 150 plasma donation centres across the US. Grifols is committed to increasing patient access to its life-saving plasma medicines through significant manufacturing expansions and the development of new therapeutic applications of plasma proteins. The company is headquartered in Barcelona, Spain, and employs more than 12,000 people worldwide.

In 2012, Grifols' sales exceeded 2,620 million euros. The company's class A shares are listed on the Spanish Stock Exchange, where they form part of the Ibex-35 (MCE:GRF).  Its non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the US NASDAQ via ADRs (NASDAQ: GRFS). For more information visit www.grifols.com.

About Alpha1-Antitrypsin Deficiency
Alpha1-antitrypsin deficiency, also known as AAT deficiency or alpha-1, is an inherited disorder that causes a significant reduction in the naturally occurring protein, alpha1-proteinase inhibitor. While rare, alpha1 is the most common cause of genetic emphysema in adults and the most common cause of liver disease in children. Individuals suffering from alpha1 often develop severe chronic obstructive pulmonary disease (COPD) leading to disability and premature death. Alpha1 is estimated to affect 200,000 people in '/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
2. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
3. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
4. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
5. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
6. Shingles Vaccine is Safe, According to New Study
7. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
8. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
9. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a ... use in portable vaporizers, which contains CBD, or ... cannabis, cannabidiol offers consumers a THC-free product made ... vaporizer technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... different compounds which are currently known, two of ...
(Date:7/11/2014)... 2014 Patient engagement has become a ... are turning to an assortment of marketing activities ... of this evolving approach to patient engagement, marketers ... engage patients throughout their experiences with a disease ... mapping the patient journey and employing a consumer ...
(Date:7/11/2014)... 2014 The consumer marketing playbook and ... sectors to better identify winning tools and techniques. ... with and understand consumers, as new technologies are ... purchasing decisions. According to recent ... area where organizations can observe a deep pool ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... ROCKVILLE, Maryland and SURESNES, France, Dec. 1, ... biotechnology company that develops next generation antibody ... company, announced today that they have entered ... for the development and commercialization of MGA271, ...
... 2011 The U.S. Food and Drug Administration today ... Lipitor (atorvastatin calcium tablets). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... approval to make generic atorvastatin calcium tablets in 10 ... The drug will be manufactured by Ohm Laboratories in ...
Cached Medicine Technology:MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 2MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 3MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug 4FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 2FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 3
(Date:7/12/2014)... According to the new market research report "Security ... Naval Systems) - Global Forecasts and Analysis to 2014 ... market are estimated to be $6.08 billion in 2014 ... to reach $8.61 billion by 2020. , Browse more ... through 161 pages and in-depth TOC on "Security and ...
(Date:7/12/2014)... 13, 2014 Recently, Fadhits.com, a well-known wedding ... elegant long graduation dresses to its product line. ... its loyal clients. It wants to bring more benefits for ... now offered at discounted prices, up to 72% off. , ... always working hard. Its online shop is a good place ...
(Date:7/12/2014)... Recently, iFitDress.com, one of the world’s leading ... red evening gowns . What’s more, all these hot outfits ... The company’s senior spokesman states, “We are proud to announce ... is an enjoyable shopping experience. In addition to the big ... low prices do not always mean bad quality. All the ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 The ... over the past five years, buoyed by stable demand ... supply management system. “Eggs are a relatively affordable staple ... capita egg consumption generally grows in line with the ... Will McKitterick. Furthermore, demand for new specialty egg products ...
(Date:7/12/2014)... Passenger Information System market is estimated to grow from ... at an expected CAGR of 26.5% for the period ... in North America is well developed and network infrastructure ... the region. The growing ridership figures in public transport ... driving the North American Passenger Information System market at ...
Breaking Medicine News(10 mins):Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:Discounted Red Evening Gown Announced by iFitDress.com 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4
... deficiencies in healthcare provision in parts of Mecklenburg-West Pomerania. ... Greifswald University and her coauthors in the current edition ... 2010; 107[18]: 328-34). They emphasize that similar trends can ... The demographic transition leads to an increase in the ...
... ... prevention of a wide range of both common and rare diseases are possible before ... ... new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is ...
... ... continues to challenge scientists. There is growing evidence that increases in protease ... team of scientists at the University of Alabama measured a common protease ... with healthy volunteers. Previous studies have shown increases in MMP-9 in CF ...
... ... Citrix and Insight Venture Partners , ... Philadelphia, PA (Vocus) May 20, 2010 -- PHD Virtual Technologies , pioneer and ... investment agreement with Citrix Systems, a leading provider of virtual computing solutions that help companies ...
... rosemary, turmeric, fingerroot inhibited production of carcinogenic compounds , ... certain spices to your burgers before tossing them on ... the flavor of the meat, but they can also ... cooking of beef. , Scientists at Kansas State University ...
... ... NanaWall Systems, Inc. announces the NanaWall SL60 is featured in the ... sponsored by the USGBC for interior designers to showcase the best ... The NanaWall connects the hotel suite to an outdoor lounge ...
Cached Medicine News:Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:News from Molecular Medicine 2Health News:PHD Virtual Technologies Announces Citrix Investment 2Health News:PHD Virtual Technologies Announces Citrix Investment 3Health News:PHD Virtual Technologies Announces Citrix Investment 4Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 3
... Donor Screening: The Procleix System ... safety to the nation's blood supply. It ... target capture, and a unique nucleic acid ... HIV-1/HCV Assay can simultaneously detect the presence ...
... Test (Reveal Test) is MedMiras flagship rapid ... human serum or plasma against HIV-1 that ... to HIV infection. The Reveal Test is ... and is comprised of a single-use test ...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
X-Hair Trephines...
Medicine Products: